C. Frank Bennett, SVP, Antisense Research at IONIS PHARMACEUTICALS INC (IONS), sold 12,500 shares at $49.54 ($619K) on 2018-11-01, disclosed to the SEC on 2018-11-01.
Open-market sale of $619k IONS by SVP, Antisense Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| IONS | SELL | 2026-02-04 | $14.1M | — | Filing → |
| IONS | SELL | 2026-02-02 | $976K | — | Filing → |
| IONS | SELL | 2026-01-20 | $675K | — | Filing → |